Literature DB >> 3311227

Successful bone marrow transplantation from an unrelated donor in a child with AML in second remission.

R Dopfer1, G Ehninger, H Schmidt, H D Waller, D Niethammer.   

Abstract

In February 1986 we transplanted a 10-year-old girl with AML in second remission with the bone marrow of an unrelated donor. HLA-types were different for one A- and one B-antigen between patient and donor. Conditioning regimen consisted of 14 Gy total body irradiation with lung shielding, 8 X 3 g/m2 cytosin arabinoside and 90 mg/kg cyclophosphamide. GVHD-prophylaxis was performed with cyclosporin A, methotrexate and prednisolone. Only mild GVHD I of the skin could be observed after rapid engraftment. 100 days after transplantation the patient was in good clinical condition and GVHD-prophylaxis was discontinued without any reactivation of acute or chronic GVHD. Engraftment was documented by sex chromosome and blood group typing. 120 days after transplantation leukemic blasts were detected in the peripheral blood and the child died 130 days after BMT from relapse of the leukemia. Despite the negative outcome, this was the first successful bone marrow transplantation from a unrelated donor in Germany.

Entities:  

Mesh:

Year:  1987        PMID: 3311227     DOI: 10.1007/BF00320090

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  7 in total

1.  Marrow transplantation from related donors other than HLA-identical siblings.

Authors:  P G Beatty; R A Clift; E M Mickelson; B B Nisperos; N Flournoy; P J Martin; J E Sanders; P Stewart; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

2.  Autologous bone marrow transplantation in treatment of leukemia, lymphomas, and other cancers.

Authors:  H Kaizer; G W Santos
Journal:  Prog Clin Cancer       Date:  1982

Review 3.  The role of autologous bone marrow transplantation in various malignancies.

Authors:  K A Dicke; S Jagannath; G Spitzer; C Poynton; A Zander; L Vellekoop; C L Reading; U W Jehn; S Tindle
Journal:  Semin Hematol       Date:  1984-04       Impact factor: 3.851

4.  [Bone marrow transplantation in leukemias in the absence of HLA-identical siblings--results of the 4th meeting of experts of the Kind-Philipp Foundation at Reisenburg 11/12 November 1985].

Authors:  D Niethammer; P Ostendorf; R Dopfer; T Klingebiel
Journal:  Klin Padiatr       Date:  1986 May-Jun       Impact factor: 1.349

5.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

Authors:  R Storb; H J Deeg; J Whitehead; F Appelbaum; P Beatty; W Bensinger; C D Buckner; R Clift; K Doney; V Farewell
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

6.  The use of partially matched, unrelated donors in clinical bone marrow transplantation.

Authors:  R D Gingrich; C W Howe; N E Goeken; G D Ginder; J W Kugler; H H Tewfik; L W Klassen; J O Armitage; M A Fyfe
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

7.  [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].

Authors:  P Ostendorf; G Ehninger; R Dopfer; H Schmidt; M Haen; H Link; K Schüch; C A Müller; P Wernet; T Klingebiel
Journal:  Klin Wochenschr       Date:  1986-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.